Cited by 1,106HIV Research and TreatmentHIV-related health complications and treatmentsHIV/AIDS Research and Interventions

The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.

. Plasma levels of soluble CD14 independently predict mortality in HIV infection.

Open access

Sandler, Netanya G., Wand, Handan, Roque, Annelys, Law, Matthew, Nason, Martha C., Nixon, Daniel E., Pedersen, Court, Ruxrungtham, Kiat, Lewin, Sharon R., Emery, Sean, Neaton, James D., Brenchley, Jason M., Deeks, Steven G., Sereti, Irini, Douek, Daniel C.·2011·The Journal of Infectious Diseases

DOI 10.1093/infdis/jiq118PMC PMC3071127

Open this paper in CoChat — free account Open PDF

Abstract

BACKGROUND: Chronic human immunodeficiency virus (HIV) infection is associated with intestinal permeability and microbial translocation that contributes to systemic immune activation, which is an independent predictor of HIV disease progression. The association of microbial translocation with clinical outcome remains unknown. METHODS: This nested case-control study included 74 subjects who died, 120 of whom developed cardiovascular disease and 81 of whom developed AIDS during the Strategies for Management of Anti-Retroviral Therapy (SMART) study with matched control subjects. Intestinal fatty acid binding protein (I-FABP), lipopolysaccharide (LPS), soluble CD14 (sCD14), endotoxin core antibody (EndoCAb), and 16S ribosomal DNA (rDNA) were measured in baseline plasma samples. RESULTS: Subjects with the highest quartile of sCD14 levels had a 6-fold higher risk of death than did those in the lowest quartile (95% confidence interval, 2.2-16.1; P<.001), with minimal change after adjustment for inflammatory markers, CD4(+) T cell count, and HIV RNA level. No other marker was significantly associated with clinical outcomes. I-FABP, LPS, and sCD14 were increased and EndoCAb was decreased in study subjects, compared with healthy volunteers. sCD14 level correlated with levels of IL-6, C-reactive protein, serum amyloid A and D-dimer. CONCLUSIONS: sCD14, a marker of monocyte response to LPS, is an independent predictor of mortality in HIV infection. Therapeutic attenuation of innate immune activation may improve survival in patients with HIV infection.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1093/infdis/jiq118

Cites

53 of 53 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Microbial translocation is a cause of systemic immune activation in chronic HIV infection
Brenchley, J. M., Price, D. A., Schacker, T. W., Asher, T. E., Silvestri, G., Rao, S., Kazzaz, Z., Bornstein, E., Lambotte, O., Altmann, D., et al. (2006) · Nature Medicine · doi:10.1038/nm1511 · Cited by 3,559
Self-citation
CD4+ Count–Guided Interruption of Antiretroviral Treatment
The Strategies for Management of Antiretroviral Therapy (SMART) Study Group (2006) · New England Journal of Medicine · doi:10.1056/nejmoa062360 · Cited by 2,250
CD4+ T Cell Depletion during all Stages of HIV Disease Occurs Predominantly in the Gastrointestinal Tract
Brenchley, J. M., Schacker, T. W., Ruff, L. E., Price, D. A., Taylor, J. H., Beilman, G. J., Nguyen, P. L., Khoruts, A., Larson, M. C., Haase, A. T., et al. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20040874 · Cited by 1,836
Self-citation
. Inflammatory and coagulation biomarkers and mortality in patients with HIV infection.
Kuller, L. H., Tracy, R., Belloso, W., Wit, S. D., Drummond, F., Lane, H. C., Ledergerber, B., Lundgren, J., Neuhaus, J., Nixon, D., et al. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050203 · Cited by 1,617
Self-citation
Gastrointestinal Tract as a Major Site of CD4 + T Cell Depletion and Viral Replication in SIV Infection
Veazey, R. S., DeMaria, M. A., Chalifoux, L. V., Shvetz, D. E., Pauley, D. R., Knight, H., Rosenzweig, M., Johnson, R. P., Desrosiers, R. C., & Lackner, A. A. (1998) · Science · doi:10.1126/science.280.5362.427 · Cited by 1,404
LPS, TLR4 and infectious disease diversity
Miller, S., Ernst, R. K., & Bader, M. W. (2005) · Nature Reviews Microbiology · doi:10.1038/nrmicro1068 · Cited by 1,059
Shorter Survival in Advanced Human Immunodeficiency Virus Type 1 Infection Is More Closely Associated with T Lymphocyte Activation than with Plasma Virus Burden or Virus Chemokine Coreceptor Usage
Giorgi, J. V., Hultin, L. E., McKeating, J. A., Johnson, T. D., Owens, B. M., Jacobson, L. P., Shih, R., Lewis, J., Wiley, D. J., Phair, J. P., et al. (1999) · The Journal of Infectious Diseases · doi:10.1086/314660 · Cited by 1,032
T Cell Activation Is Associated with Lower CD4+T Cell Gains in Human Immunodeficiency Virus–Infected Patients with Sustained Viral Suppression during Antiretroviral Therapy
Hunt, P. W., Martin, J. N., Sinclair, E., Bredt, B. M., Hagos, E., Lampiris, H. W., & Deeks, S. G. (2003) · The Journal of Infectious Diseases · doi:10.1086/374786 · Cited by 852
Self-citation
Immune activation set point during early HIV infection predicts subsequent CD4+ T-cell changes independent of viral load
Deeks, S. G., Ramirez, C. M., Liu, L., Guo, H., Gascon, R., Narváez, A. B., Hunt, P. W., Martin, J. N., Kahn, J. S., Levy, J. A., et al. (2004) · Blood · doi:10.1182/blood-2003-09-3333 · Cited by 803
Self-citation
Plasma Levels of Bacterial DNA Correlate with Immune Activation and the Magnitude of Immune Restoration in Persons with Antiretroviral‐Treated HIV Infection
Jiang, W., Lederman, M. M., Hunt, P. W., Sieg, S. F., Haley, K. P., Rodriguez, B. A., LANDAY, A. L., Martin, J. N., Sinclair, E., Asher, A. I., et al. (2009) · The Journal of Infectious Diseases · doi:10.1086/597476 · Cited by 598
Self-citation

Show all 50 references

Sorted by citations

Items 101–200 of 1,000

Premature Aging and Premature Age-Related Comorbidities in HIV-Infected Patients: Facts and Hypotheses
Capeau, J. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir628 · Cited by 125
Quality and quantity of T FH cells are critical for broad antibody development in SHIV AD8 infection
Yamamoto, T., Lynch, R. M., Gautam, R., Matus‐Nicodemos, R., Schmidt, S. D., Boswell, K. L., Darko, S. W., Wong, P., Sheng, Z., Petrovas, C., et al. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aab3964 · Cited by 124
Self-citation
Fecal Microbiota Composition Drives Immune Activation in HIV-infected Individuals
Neff, C. P., Krueger, O., Xiong, K., Arif, S. J., Nusbacher, N. M., Schneider, J. M., Cunningham, A. W., Armstrong, A. J. S., Li, S., McCarter, M. D., et al. (2018) · EBioMedicine · doi:10.1016/j.ebiom.2018.03.024 · Cited by 122
Aging with HIV
Guaraldi, G., Milić, J., & Mussini, C. (2019) · Current HIV/AIDS Reports · doi:10.1007/s11904-019-00464-3 · Cited by 118
Evidence for Polymicrobic Flora Translocating in Peripheral Blood of HIV-Infected Patients with Poor Immune Response to Antiretroviral Therapy
Merlini, E., Bai, F., Bellistrì, G. M., Tincati, C., Monforte, A. D., & Marchetti, G. C. (2011) · PLoS ONE · doi:10.1371/journal.pone.0018580 · Cited by 119
Mycobacterial Antigen Driven Activation of CD14++CD16− Monocytes Is a Predictor of Tuberculosis-Associated Immune Reconstitution Inflammatory Syndrome
Andrade, B. B., Singh, A., Narendran, G., Schechter, M., Nayak, K., Subramanian, S., Selvaraj, A., Jensen, S. M. R., Porter, B. O., Antonelli, L. R. D. V., et al. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1004433 · Cited by 117
Self-citation
Changes in Inflammation and Immune Activation With Atazanavir-, Raltegravir-, Darunavir-Based Initial Antiviral Therapy: ACTG 5260s
Kelesidis, T., Tran, T. T. T., Stein, J. H., Brown, T. T., Moser, C., Ribaudo, H. J., Dubé, M. P., Murphy, R. L., Yang, O. O., Currier, J. S., et al. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ327 · Cited by 115
Gut microbiota changes and chronic hepatitis C virus infection
Preveden, T., Scarpellini, E., Milić, N., Luzza, F., & Abenavoli, L. (2017) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2017.1343663 · Cited by 97
Association of Macrophage Inflammation Biomarkers With Progression of Subclinical Carotid Artery Atherosclerosis in HIV-Infected Women and Men
Hanna, D. B., Lin, J., Post, W. S., Hodis, H. N., Xue, X., Anastos, K., Cohen, M. H., Gange, S. J., Haberlen, S., Heath, S. L., et al. (2017) · The Journal of Infectious Diseases · doi:10.1093/infdis/jix082 · Cited by 113
The Th17/Treg Ratio, IL-1RA and sCD14 Levels in Primary HIV Infection Predict the T-cell Activation Set Point in the Absence of Systemic Microbial Translocation
Chevalier, M. F., Petitjean, G., Dunyach‐Remy, C., Didier, C., Girard, P., Manea, M. E., Campa, P., Meyer, L., Rouzioux, C., Lavigne, J., et al. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003453 · Cited by 122
Tobacco Smoking Increases Immune Activation and Impairs T-Cell Function in HIV Infected Patients on Antiretrovirals: A Cross-Sectional Pilot Study
Valiathan, R., Míguez, M. J., Patel, B., Arheart, K. L., & Asthana, D. (2014) · PLoS ONE · doi:10.1371/journal.pone.0097698 · Cited by 107
HIV-Nef and ADAM17-Containing Plasma Extracellular Vesicles Induce and Correlate with Immune Pathogenesis in Chronic HIV Infection
Lee, J., Schierer, S., Blume, K., Dindorf, J., Wittki, S., Xiang, W., Ostalecki, C., Koliha, N., Wild, S., Schuler, G., et al. (2016) · EBioMedicine · doi:10.1016/j.ebiom.2016.03.004 · Cited by 107
CD32 is expressed on cells with transcriptionally active HIV but does not enrich for HIV DNA in resting T cells
Abdel‐Mohsen, M., Kuri-Cervantes, L., Grau-Expósito, J., Spivak, A. M., Nell, R. A., Tomescu, C., Vadrevu, S. K., Giron, L. B., Serra‐Peinado, C., Genescà, M., et al. (2018) · Science Translational Medicine · doi:10.1126/scitranslmed.aar6759 · Cited by 113
Do Biomarkers of Inflammation, Monocyte Activation, and Altered Coagulation Explain Excess Mortality Between HIV Infected and Uninfected People?
So‐Armah, K., Tate, J. P., Chang, C. H., Butt, A. A., Gerschenson, M., Gibert, C. L., Leaf, D. A., Rimland, D., Rodriguez‐Barradas, M. C., Budoff, M. J., et al. (2016) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000000954 · Cited by 111
Self-citation
HIV-1 infection induces strong production of IP-10 through TLR7/9-dependent pathways
Simmons, R. P., Scully, E. P., Groden, E. E., Arnold, K. B., Chang, J. J., Lane, K., Lifson, J. D., Rosenberg, E. S., Lauffenburger, D. A., & Altfeld, M. A. (2013) · AIDS · doi:10.1097/01.aids.0000432455.06476.bc · Cited by 106
Pro-Inflammatory Markers in Relation to Cardiovascular Disease in HIV Infection. A Systematic Review
Vos, A. G., Idris, N. S., Barth, R. E., Klipstein‐Grobusch, K., & Grobbee, D. E. (2016) · PLoS ONE · doi:10.1371/journal.pone.0147484 · Cited by 106
Risk of coronary heart disease in patients with HIV infection
Zanni, M. V., Schouten, J., Grinspoon, S. K., & Reiss, P. (2014) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2014.167 · Cited by 107
Markers of coagulation and inflammation often remain elevated in ART-treated HIV-infected patients
Funderburg, N. (2013) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0000000000000019 · Cited by 105
Increased Risk of Radiographic Emphysema in HIV Is Associated With Elevated Soluble CD14 and Nadir CD4
Attia, E. F., Akgün, K. M., Wongtrakool, C., Goetz, M. B., Rodriguez‐Barradas, M. C., Rimland, D., Brown, S. T., Hoo, G. W. S., Kim, J. M., Lee, P. J., et al. (2014) · CHEST Journal · doi:10.1378/chest.14-0543 · Cited by 104
Cotrimoxazole reduces systemic inflammation in HIV infection by altering the gut microbiome and immune activation
Bourke, C. D., Gough, E. K., Pimundu, G., Shonhai, A., Berejena, C., Terry, L., Baumard, L., Choudhry, N., Karmali, Y., Bwakura‐Dangarembizi, M., et al. (2019) · Science Translational Medicine · doi:10.1126/scitranslmed.aav0537 · Cited by 104
Serious Non-AIDS Events: Therapeutic Targets of Immune Activation and Chronic Inflammation in HIV Infection
Hsu, D. C., & Sereti, I. (2016) · Drugs · doi:10.1007/s40265-016-0546-7 · Cited by 102
Self-citation
HIV-associated changes in the enteric microbial community: potential role in loss of homeostasis and development of systemic inflammation
Gootenberg, D. B., Paer, J. M., Luévano, J. M., & Kwon, D. S. (2016) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000000341 · Cited by 103
Inflammatory monocytes expressing tissue factor drive SIV and HIV coagulopathy
Schechter, M., Andrade, B. B., He, T., Richter, G. H., Tosh, K. W., Policicchio, B. B., Singh, A., Raehtz, K. D., Sheikh, V., Ma, D., et al. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aam5441 · Cited by 103
Self-citation
Enrichment of gut-derived Fusobacterium is associated with suboptimal immune recovery in HIV-infected individuals
Lee, S. C., Chua, L. L., Yap, S. H., Khang, T. F., Leng, C. Y., Azwa, I., Lewin, S. R., Kamarulzaman, A., Woo, Y. L., Lim, Y. A. L., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-32585-x · Cited by 103
Self-citation
Oxidized LDL Levels Are Increased in HIV Infection and May Drive Monocyte Activation
Zidar, D. A., Juchnowski, S. M., Ferrari, B., Clagett, B. M., Pilch-Cooper, H. A., Rose, S. M., Rodriguez, B. A., McComsey, G. A., Sieg, S. F., Mehta, N. N., et al. (2015) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000000566 · Cited by 102
MAIT cells are depleted early but retain functional cytokine expression in HIV infection
Fernandez, C. S., Amarasena, T. H., Kelleher, A. D., Rossjohn, J., McCluskey, J., Godfrey, D. I., & Kent, S. J. (2014) · Immunology and Cell Biology · doi:10.1038/icb.2014.91 · Cited by 106
Replicative fitness of transmitted HIV-1 drives acute immune activation, proviral load in memory CD4 + T cells, and disease progression
Claiborne, D. T., Prince, J. L., Scully, E. P., Macharia, G. N., Micci, L., Lawson, B., Kopycinski, J. T., Deymier, M. J., Vanderford, T. H., Nganou‐Makamdop, K., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1421607112 · Cited by 102
Self-citation
CD8+ T-Cell Response to HIV Infection in the Era of Antiretroviral Therapy
Perdomo-Celis, F., Taborda, N. A., & Rugeles, M. T. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01896 · Cited by 103
Elevated IP10 levels are associated with immune activation and low CD4+ T-cell counts in HIV controller patients
Noël, N., Boufassa, F., Lécuroux, C., Sáez‐Cirión, A., Bourgeois, C., Dunyach‐Remy, C., Goujard, C., Rouzioux, C., Meyer, L., Pancino, G., et al. (2013) · AIDS · doi:10.1097/qad.0000000000000174 · Cited by 100
Monocyte-Activation Phenotypes Are Associated With Biomarkers of Inflammation and Coagulation in Chronic HIV Infection
Wilson, E. M. P., Singh, A., Hullsiek, K. H., Gibson, D., Henry, W. K., Lichtenstein, K., Önen, N. F., Kojic, E. M., Patel, P., Brooks, J. T., et al. (2014) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiu275 · Cited by 100
Self-citation
Persistent immune activation in chronic HIV infection
Rajasuriar, R., Khoury, G., Kamarulzaman, A., French, M. A., Cameron, P. U., & Lewin, S. R. (2013) · AIDS · doi:10.1097/qad.0b013e32835ecb8b · Cited by 102
Self-citation
Decreases in Colonic and Systemic Inflammation in Chronic HIV Infection after IL-7 Administration
Sereti, I., Estes, J. D., Thompson, W. L., Morcock, D. R., Fischl, M. A., Croughs, T., Beq, S., de Micheaux, S. L., Yao, M. D., Ober, A., et al. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1003890 · Cited by 102
Self-citation
Cardiovascular Disease and Thrombosis in HIV Infection
Perkins, M. V., Joseph, S., Dittmer, D. P., & Mackman, N. (2022) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.122.318232 · Cited by 98
Virological and immunological characteristics of HIV-infected individuals at the earliest stage of infection
Ananworanich, J., Sacdalan, C., Pinyakorn, S., Chomont, N., de Souza, M. S., Luekasemsuk, T., Schuetz, A., Krebs, S. J., Dewar, R. L., Jagodzinski, L. L., et al. (2016) · Journal of Virus Eradication · doi:10.1016/s2055-6640(20)30688-9 · Cited by 99
Self-citation
Effects of Fecal Microbial Transplantation on Microbiome and Immunity in Simian Immunodeficiency Virus-Infected Macaques
Hensley‐McBain, T., Zevin, A. S., Manuzak, J. A., Smith, E. A., Gile, J., Miller, C. J., Agricola, B. A., Katze, M. G., Reeves, R. K., Kraft, C. S., et al. (2016) · Journal of Virology · doi:10.1128/jvi.00099-16 · Cited by 94
HIV Pathogenesis: The HostPreprint
Lackner, A. A., Lederman, M. M., & Rodriguez, B. A. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a007005 · Cited by 107
Latent and Active Tuberculosis Infection Increase Immune Activation in Individuals Co-Infected with HIV
Sullivan, Z. A., Wong, E. B., Ndung’u, T., Kasprowicz, V. O., & Bishai, W. R. (2015) · EBioMedicine · doi:10.1016/j.ebiom.2015.03.005 · Cited by 95
Inflammation, Immune Activation, and CVD Risk in Individuals With HIV Infection
Stein, J. H., & Hsue, P. Y. (2012) · JAMA · doi:10.1001/jama.2012.8488 · Cited by 94
Influence of Age at Virologic Control on Peripheral Blood Human Immunodeficiency Virus Reservoir Size and Serostatus in Perinatally Infected Adolescents
Persaud, D., Patel, K., Karalius, B., Rainwater‐Lovett, K., Ziemniak, C., Ellis, A., Chen, Y. H., Richman, D. D., Siberry, G. K., Dyke, R. B. V., et al. (2014) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/jamapediatrics.2014.1560 · Cited by 94
Interferon‐alpha, immune activation and immune dysfunction in treated HIV infection
Cha, L., Berry, C., Nolan, D. A., Castley, A., Fernández, S., & French, M. A. (2014) · Clinical & Translational Immunology · doi:10.1038/cti.2014.1 · Cited by 97
Central and peripheral markers of neurodegeneration and monocyte activation in HIV-associated neurocognitive disorders
McGuire, J. L., Gill, A. J., Douglas, S. D., & Kolson, D. L. (2015) · Journal of NeuroVirology · doi:10.1007/s13365-015-0333-3 · Cited by 96
Immunologic predictors of coronary artery calcium progression in a contemporary HIV cohort
Baker, J. V., Hullsiek, K. H., Singh, A., Wilson, E. M. P., Henry, K., Lichtenstein, K., Önen, N. F., Kojic, E. M., Patel, P., Brooks, J. T., et al. (2013) · AIDS · doi:10.1097/qad.0000000000000145 · Cited by 96
Self-citation
Early microbial translocation blockade reduces SIV-mediated inflammation and viral replication
Kristoff, J., Haret-Richter, G. S., Ma, D., Ribeiro, R. M., Xu, C., Cornell, E. S., Stock, J. L., He, T., Mobley, A. D., Ross, S., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci75090 · Cited by 91
Immune Activation in HIV-Infected Aging Women on Antiretrovirals—Implications for Age-Associated Comorbidities: A Cross-Sectional Pilot Study
Alcaide, M. L., Parmigiani, A., Pallikkuth, S., Roach, M. E., Freguja, R., Negra, M. D., Bolívar, H., Fischl, M. A., & Pahwa, S. G. (2013) · PLoS ONE · doi:10.1371/journal.pone.0063804 · Cited by 92
Pathophysiology and management of cardiovascular disease in patients with HIV
Nou, E., Lo, J., Hadigan, C. M., & Grinspoon, S. K. (2016) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(15)00388-5 · Cited by 95
Circulating Interleukin-6 Levels Correlate with Residual HIV Viraemia and Markers of Immune Dysfunction in Treatment-Controlled HIV-Infected Patients
Bastard, J., Soulié, C., Fellahi, S., Haïm‐Boukobza, S., Simon, A., Katlama, C., Cálvez, V., Marcelin, A., & Capeau, J. (2012) · Antiviral Therapy · doi:10.3851/imp2093 · Cited by 90
A 48-week randomized phase 2b study evaluating cenicriviroc versus efavirenz in treatment-naive HIV-infected adults with C-C chemokine receptor type 5-tropic virus
Thompson, M., Saag, M. S., DeJesus, E., Gathe, J., Lalezari, J. P., LANDAY, A. L., Cade, J. L., Enejosa, J., Lefebvre, E. A., & Feinberg, J. (2015) · AIDS · doi:10.1097/qad.0000000000000988 · Cited by 91
Impact of antiretroviral drugs on the microbiome
Pinto-Cardoso, S. M., Klatt, N. R., & Reyes‐Terán, G. (2017) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0000000000000428 · Cited by 90
Complexities of Gut Microbiome Dysbiosis in the Context of HIV Infection and Antiretroviral Therapy
Li, X., Armstrong, A., Neff, C. P., Shaffer, M., Lozupone, C., & Palmer, B. E. (2016) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.363 · Cited by 93
Inflammatory Biomarkers and Mortality Risk Among HIV-Suppressed Men: A Multisite Prospective Cohort Study
Wada, N., Bream, J. H., Martı́nez-Maza, O., Macatangay, B. J. C., Galvin, S., Margolick, J. B., & Jacobson, L. P. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw409 · Cited by 87
Fecal Bacterial Communities in treated HIV infected individuals on two antiretroviral regimens
Pinto-Cardoso, S. M., Lozupone, C., Briceño, O., Alva-Hernández, S., Téllez-Navarrete, N. A., Adriana, A., Murakami-Ogasawara, A., & Reyes‐Terán, G. (2017) · Scientific Reports · doi:10.1038/srep43741 · Cited by 92
Effects of pitavastatin and pravastatin on markers of immune activation and arterial inflammation in HIV
Toribio, M. P., Fitch, K. V., Sánchez, L. P., Burdo, T. H., Williams, K. C., Sponseller, C. A., Pate, M. M., Aberg, J. A., Zanni, M. V., & Grinspoon, S. K. (2017) · AIDS · doi:10.1097/qad.0000000000001427 · Cited by 87
Factors Associated with Siman Immunodeficiency Virus Transmission in a Natural African Nonhuman Primate Host in the Wild
Ma, D., Jasinska, A. J., Feyertag, F., Wijewardana, V., Kristoff, J., He, T., Raehtz, K. D., Schmitt, C. A., Jung, Y., Cramer, J. D., et al. (2014) · Journal of Virology · doi:10.1128/jvi.03606-13 · Cited by 86
Microbial Translocation in HIV Infection Is Associated With Dyslipidemia, Insulin Resistance, and Risk of Myocardial Infarction
Pedersen, K. K., Pedersen, M., Trøseid, M., Gaardbo, J. C., Lund, T. T., Thomsen, C., Gerstoft, J., Kvale, D., & Nielsen, S. D. (2013) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e31829f919d · Cited by 83
Differential Reduction in Monocyte Activation and Vascular Inflammation With Integrase Inhibitor–Based Initial Antiretroviral Therapy Among HIV-Infected Individuals
Hileman, C. O., Kinley, B., Scharen-Guivel, V., Melbourne, K., Szwarcberg, J., Robinson, J., Lederman, M. M., & McComsey, G. A. (2015) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiv004 · Cited by 84
Inflammatory Cytokines Drive CD4+ T-Cell Cycling and Impaired Responsiveness to Interleukin 7: Implications for Immune Failure in HIV Disease
Shive, C. L., Mudd, J. C., Funderburg, N., Sieg, S. F., Kyi, B., Bazdar, D. A., Mangioni, D., Gori, A., Jacobson, J. M., Brooks, A. D., et al. (2014) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiu125 · Cited by 82
Sevelamer Does Not Decrease Lipopolysaccharide or Soluble CD14 Levels But Decreases Soluble Tissue Factor, Low-Density Lipoprotein (LDL) Cholesterol, and Oxidized LDL Cholesterol Levels in Individuals With Untreated HIV Infection
Utay, N. S., Zhang, X., Bosch, R. J., Funderburg, N., Choi, A. I., Robinson, J., Fine, D. M., Coombs, R. W., Jacobson, J. M., LANDAY, A. L., et al. (2014) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiu305 · Cited by 83
Self-citation
Systemic Inflammation, Coagulation, and Clinical Risk in the START Trial
Baker, J. V., Sharma, S., Grund, B., Rupert, A. W., Metcalf, J. A., Schechter, M., Munderi, P., Aho, I., Emery, S., Babiker, A. G., et al. (2017) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofx262 · Cited by 83
Self-citation
Increased Serum Levels of sCD14 and sCD163 Indicate a Preponderant Role for Monocytes in COVID-19 Immunopathology
Rial, J. G., Currás-Tuala, M. J., Calle, I. R., Gómez‐Carballa, A., Cebey‐López, M., Rodrı́guez-Tenreiro, C., Dacosta-Urbieta, A. I., Rivero-Velasco, C., Rodríguez‐Núñez, N., Trastoy, R., et al. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.560381 · Cited by 83
Biomarkers of Immune Dysfunction Following Combination Antiretroviral Therapy for HIV Infection
Lichtfuss, G. F., Hoy, J., Rajasuriar, R., Kramski, M., Crowe, S. M., & Lewin, S. R. (2011) · Biomarkers in Medicine · doi:10.2217/bmm.11.15 · Cited by 86
Self-citation
Persistent Immune Activation and Carotid Atherosclerosis in HIV-Infected Ugandans Receiving Antiretroviral Therapy
Siedner, M. J., Kim, J., Sentongo, R. N., Bibangambah, P., Hemphill, L., Triant, V. A., Haberer, J. E., Martin, J. N., Mocello, A. R., Boum, Y., et al. (2015) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiv450 · Cited by 82
Inflammatory Co-morbidities in HIV+ Individuals: Learning Lessons from Healthy Ageing
Hearps, A. C., Martin, G. E., Rajasuriar, R., & Crowe, S. M. (2014) · Current HIV/AIDS Reports · doi:10.1007/s11904-013-0190-8 · Cited by 84
Role of the macrophage in HIV-associated neurocognitive disorders and other comorbidities in patients on effective antiretroviral treatment
Rappaport, J., & Volsky, D. J. (2015) · Journal of NeuroVirology · doi:10.1007/s13365-015-0346-y · Cited by 81
Immune activation and HIV persistence
Hatano, H. (2013) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0b013e32835f9788 · Cited by 83
Long-Term Suppressive Combined Antiretroviral Treatment Does Not Normalize the Serum Level of Soluble CD14
Méndez‐Lagares, G., Romero-Sánchez, M. C., Ruíz-Mateos, E., Genebat, M., Ferrando‐Martínez, S., Muñoz‐Fernández, M. Á., Pacheco, Y. M., & Leal, M. (2013) · The Journal of Infectious Diseases · doi:10.1093/infdis/jit025 · Cited by 81
Myeloid Cell Interaction with HIV: A Complex Relationship
Rodrigues, V., Ruffin, N., Jouve, M. J., & Benaroch, P. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01698 · Cited by 81
Immunomodulation of Antiretroviral Drug-Suppressed Chronic HIV-1 Infection in an Oral Probiotic Double-Blind Placebo-Controlled Trial
Yang, O. O., Kelesidis, T., Cordova, R., & Khanlou, H. (2014) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2014.0181 · Cited by 81
Sex Differences in Neurocognitive Function in Adults with HIV: Patterns, Predictors, and Mechanisms
Rubin, L. H., Neigh, G. N., Sundermann, E. E., Xu, Y., Scully, E. P., & Maki, P. M. (2019) · Current Psychiatry Reports · doi:10.1007/s11920-019-1089-x · Cited by 80
Associations between Cognition, Gender and Monocyte Activation among HIV Infected Individuals in Nigeria
Royal, W., Cherner, M., Burdo, T. H., Umlauf, A., Letendre, S. L., Jumare, J., Abimiku, A., Alabi, P., Alkali, N. H., Bwala, S. A., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0147182 · Cited by 82
Rifaximin has a Marginal Impact on Microbial Translocation, T-cell Activation and Inflammation in HIV-Positive Immune Non-responders to Antiretroviral Therapy – ACTG A5286
Tenorio, A. R., Chan, E. S., Bosch, R. J., Macatangay, B. J. C., Read, S. W., Yesmin, S., Taiwo, B., Margolis, D. M., Jacobson, J. M., LANDAY, A. L., et al. (2014) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiu515 · Cited by 78
HIV-exposed-uninfected infants have increased inflammation and monocyte activation
Dirajlal‐Fargo, S., Mussi‐Pinhata, M. M., Weinberg, A., Yu, Q., Cohen, R., Harris, D. R., Bowman, E., Gabriel, J., Kulkarni, M., Funderburg, N., et al. (2019) · AIDS · doi:10.1097/qad.0000000000002128 · Cited by 78
Residual immune dysfunction under antiretroviral therapy
Cai, C. W., & Sereti, I. (2021) · Seminars in Immunology · doi:10.1016/j.smim.2021.101471 · Cited by 80
Self-citation
Translocated microbiome composition determines immunological outcome in treated HIV infection
Nganou‐Makamdop, K., Talla, A., Sharma, A., Darko, S. W., Ransier, A., Laboune, F., Chipman, J. G., Beilman, G. J., Hoskuldsson, T., Fourati, S., et al. (2021) · Cell · doi:10.1016/j.cell.2021.05.023 · Cited by 84
Self-citation
The Many Faces of Immune Activation in HIV-1 Infection: A Multifactorial Interconnection
Mazzuti, L., Turriziani, O., & Mezzaroma, I. (2023) · Biomedicines · doi:10.3390/biomedicines11010159 · Cited by 77
Galectin-9 Is Rapidly Released During Acute HIV-1 Infection and Remains Sustained at High Levels Despite Viral Suppression Even in Elite Controllers
Tandon, R., Chew, G. M., Byron, M. M., Borrow, P., Niki, T., Hirashima, M., Barbour, J. D., Norris, P. J., Lanteri, M. C., Martin, J. N., et al. (2014) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2014.0004 · Cited by 77
Self-citation
Accelerated aging and human immunodeficiency virus infection: Emerging challenges of growing older in the era of successful antiretroviral therapy
Bhatia, R., Ryscavage, P., & Taiwo, B. (2011) · Journal of NeuroVirology · doi:10.1007/s13365-011-0073-y · Cited by 80
Inside Out: HIV, the Gut Microbiome, and the Mucosal Immune System
Liu, J., Williams, B., Frank, D. N., Dillon, S. M., Wilson, C. C., & LANDAY, A. L. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1601355 · Cited by 77
Reduced Levels of D-dimer and Changes in Gut Microbiota Composition After Probiotic Intervention in HIV-Infected Individuals on Stable ART
Stiksrud, B., Nowak, P., Nwosu, F. C., Kvale, D., Thalme, A., Sönnerborg, A. B., Ueland, P. M., Holm, K., Birkeland, S., Dahm, A. E. A., et al. (2015) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000000784 · Cited by 77
Soluble biomarkers of HIV transmission, disease progression and comorbidities
Leeansyah, E., Malone, D. F. G., Anthony, D. D., & Sandberg, J. K. (2012) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0b013e32835c7134 · Cited by 76
Early ART After Cryptococcal Meningitis Is Associated With Cerebrospinal Fluid Pleocytosis and Macrophage Activation in a Multisite Randomized Trial
Scriven, J. E., Rhein, J., Hullsiek, K. H., von Hohenberg, M., Linder, G., Rolfes, M. A. R., Williams, D. A., Taseera, K., Meya, D. B., Meintjes, G., et al. (2015) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiv067 · Cited by 75
Sex-Related Differences in Inflammatory and Immune Activation Markers Before and After Combined Antiretroviral Therapy Initiation
Mathad, J. S., Gupte, N., Balagopal, A., Asmuth, D. M., Hakim, J. G., Santos, B. R., Riviere, C., Hosseinipour, M. C., Sugandhavesa, P., Infante, R. M., et al. (2016) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000001095 · Cited by 75
Serious Non-AIDS events: Immunopathogenesis and interventional strategies
Hsu, D. C., Sereti, I., & Ananworanich, J. (2013) · AIDS Research and Therapy · doi:10.1186/1742-6405-10-29 · Cited by 73
Self-citation
Chronic HIV infection induces transcriptional and functional reprogramming of innate immune cells
van der Heijden, W. A., de Wijer, L. V., Keramati, F., Trypsteen, W., Rutsaert, S., ter Horst, R., Jaeger, M., Koenen, H. J. P. M., Stunnenberg, H. G., Joosten, I., et al. (2021) · JCI Insight · doi:10.1172/jci.insight.145928 · Cited by 73
The Role of Transforming Growth Factor Beta-1 in the Progression of HIV/AIDS and Development of Non-AIDS-Defining Fibrotic Disorders
Theron, A. J., Anderson, R., Rossouw, T. M., & Steel, H. C. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01461 · Cited by 78
Lipid Abnormalities in Persons Living With HIV Infection
Waters, D. D., & Hsue, P. Y. (2018) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2018.11.005 · Cited by 75
T-Cell Phenotypes, Apoptosis and Inflammation in HIV+ Patients on Virologically Effective cART with Early Atherosclerosis
Merlini, E., Luzi, K., Suardi, E., Barassi, A., Cerrone, M., Sánchez‐Martínez, J., Bai, F., d’Eril, G. V. M., Monforte, A. D., & Marchetti, G. C. (2012) · PLoS ONE · doi:10.1371/journal.pone.0046073 · Cited by 73
Macrophage Inflammatory Markers Are Associated With Subclinical Carotid Artery Disease in Women With Human Immunodeficiency Virus or Hepatitis C Virus Infection
Shaked, I., Hanna, D. B., Gleißner, C., Marsh, B. J., Plants, J., Tracy, D., Anastos, K., Cohen, M. H., Golub, E. T., Karim, R., et al. (2014) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.113.303153 · Cited by 73
CD4/CD8 ratio normalization rates and low ratio as prognostic marker for non-AIDS defining events among long-term virologically suppressed people living with HIV
Han, W. M., Apornpong, T., Kerr, S. J., Hiransuthikul, A., Gatechompol, S., Do, T., Ruxrungtham, K., & Avihingsanon, A. (2018) · AIDS Research and Therapy · doi:10.1186/s12981-018-0200-4 · Cited by 76
Self-citation
Low-Level HIV Viremia Is Associated With Microbial Translocation and Inflammation
Reus, S., Portilla, J., Sánchez–Payá, J., Giner, L., Francés, R., Such, J. M., Boix, V., Merino, E., & Gimeno, A. (2012) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e3182745ab0 · Cited by 73
Associations of Soluble CD14 and Endotoxin with Mortality, Cardiovascular Disease, and Progression of Kidney Disease among Patients with CKD
Poesen, R., Ramezani, A., Claes, K. J., Augustijns, P., Kuypers, D. R. J., Barrows, I. R., Jagadeesan, M., Evenepoel, P., Meijers, B. K. I., & Raj, D. S. (2015) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.03100315 · Cited by 73
A benchmark for evaluation of algorithms for identification of cellular correlates of clinical outcomes
Aghaeepour, N., Chattopadhyay, P. K., Chikina, M. D., Dhaene, T., Gassen, S. V., Kursa, M. B., Lambrecht, B. N., Malek, M., McLachlan, G. J., Yu, Q., et al. (2015) · Cytometry Part A · doi:10.1002/cyto.a.22732 · Cited by 68
Inflammation and Change in Body Weight With Antiretroviral Therapy Initiation in a Multinational Cohort of HIV-Infected Adults
Mave, V., Erlandson, K. M., Gupte, N., Balagopal, A., Asmuth, D. M., Campbell, T., Smeaton, L. M., Kumarasamy, N., Hakim, J., Santos, B. R., et al. (2016) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiw096 · Cited by 76
Role of immune activation in progression to AIDS
Utay, N. S., & Hunt, P. W. (2016) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0000000000000242 · Cited by 73
Limited engraftment of donor microbiome via one-time fecal microbial transplantation in treated HIV-infected individuals
Vujkovic-Cvijin, I., Rutishauser, R. L., Pao, M., Hunt, P. W., Lynch, S. V., McCune, J. M., & Somsouk, M. (2017) · Gut Microbes · doi:10.1080/19490976.2017.1334034 · Cited by 74
Markers of microbial translocation and risk of AIDS-related lymphoma
Marks, M. A., Rabkin, C. S., Engels, E. A., Busch, E. L., Kopp, W., Rager, H., Goedert, J. J., & Chaturvedi, A. K. (2012) · AIDS · doi:10.1097/qad.0b013e32835c1333 · Cited by 72
An NK Cell Population Lacking FcRγ Is Expanded in Chronically Infected HIV Patients
Zhou, J., Amran, F. S., Kramski, M., Angelovich, T. A., Elliott, J. H., Hearps, A. C., Price, P., & Jaworowski, A. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1402448 · Cited by 71
A Randomized Placebo Controlled Trial of Aspirin Effects on Immune Activation in Chronically Human Immunodeficiency Virus-Infected Adults on Virologically Suppressive Antiretroviral Therapy
O’Brien, M. P., Hunt, P. W., Kitch, D. W., Klingman, K. L., Stein, J. H., Funderburg, N., Berger, J. S., Tebas, P., Clagett, B. M., Moisi, D. D., et al. (2017) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofw278 · Cited by 72
Oral serum-derived bovine immunoglobulin improves duodenal immune reconstitution and absorption function in patients with HIV enteropathy
Asmuth, D. M., Ma, Z.-M., Albanese, A. P., Utay, N. S., Devaraj, S., Knight, T. H., Flynn, N. M., Yotter, T., Garcia, J.-C., Tsuchida, E., et al. (2013) · AIDS · doi:10.1097/qad.0b013e328362e54c · Cited by 71
Self-citation
Role of inflammation in HIV-1 disease progression and prognosis
Ipp, H., Zemlin, A. E., Erasmus, R. T., & Glashoff, R. H. (2014) · Critical Reviews in Clinical Laboratory Sciences · doi:10.3109/10408363.2013.865702 · Cited by 72
Mucosal immunity in human and simian immunodeficiency lentivirus infections
Brenchley, J. M. (2013) · Mucosal Immunology · doi:10.1038/mi.2013.15 · Cited by 70
Self-citation

Authors: Sandler, N. G., Wand, H., Roque, A., Law, M., Nason, M. C., Nixon, D. E., Pedersen, C., Ruxrungtham, K., Lewin, S. R., Emery, S., Neaton, J. D., Brenchley, J. M., Deeks, S. G., Sereti, I., & Douek, D. C.
Affiliations: UNSW Sydney (AU)
National Institutes of Health (US)
Virginia Commonwealth University (US)
University of Southern Denmark (DK)
Chulalongkorn University (TH)
Burnet Institute (AU)
University of Minnesota (US)
San Francisco General Hospital (US)
ORCID: Wand, Handan
Law, Matthew
Nason, Martha C.
Ruxrungtham, Kiat
Lewin, Sharon R.
Emery, Sean
Neaton, James D.
Brenchley, Jason M.
Deeks, Steven G.
Sereti, Irini
Douek, Daniel C.
Venue: The Journal of Infectious Diseases
Publisher: Oxford University Press (OUP)
Published: 2011-03-15
Volume: 203
Issue: 6
Pages: 780-790
ISSN: 0022-1899 (ISSN-L)
1537-6613
DOI: 10.1093/infdis/jiq118
PMC: PMC3071127
OpenAlex: W2098152094
Cited by: 1,106
References: 50
Citations by year: 2026: 32 · 2025: 31 · 2024: 59 · 2023: 48 · 2022: 67 · 2021: 70 · 2020: 76 · 2019: 70 · 2018: 69 · 2017: 83 · 2016: 107 · 2015: 97 · 2014: 111 · 2013: 93 · 2012: 65
FWCI: 37.22
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: The Journal of Infectious Diseases (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
University of Southern Denmark Research Portal (University of Southern Denmark) (submittedVersion)
Funders: National Center for Genetic Engineering and Biotechnology
National Institutes of Health
National Institute of Allergy and Infectious Diseases (AI 76174, P01AI076174)
Topics: Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
Health Sciences › Medicine › Infectious Diseases › HIV-related health complications and treatments
Health Sciences › Medicine › Infectious Diseases › HIV/AIDS Research and Interventions
Keywords: soluble CD14, HIV infection, mortality prediction, microbial translocation, intestinal permeability, lipopolysaccharide, endotoxin core antibody, intestinal fatty acid binding protein, cardiovascular disease, AIDS, innate immune activation, SMART trial, prognostic factors
MeSH terms: Adult, Cause of Death, Humans, Lipopolysaccharides, Male, Middle Aged, RNA, Viral, Biomarkers, CD4-Positive T-Lymphocytes, HIV Infections, Logistic Models, Case-Control Studies, Lipopolysaccharide Receptors, Fatty Acid-Binding Proteins, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

. Plasma levels of soluble CD14 independently predict mortality in HIV infection.

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks